Increased [18F]fluorodeoxyglucose accumulation in right ventricular free wall in patients with pulmonary hypertension and the effect of epoprostenol.

[1]  L. Ginzton,et al.  Echocardiographic Assessment of the Right Ventricular Stress–Velocity Relationship Under Normal and Chronic Overload Conditions , 2004, Echocardiography.

[2]  G. Paolisso,et al.  Low-dose Iloprost infusion improves insulin action and non-oxidative glucose metabolism in hypertensive patients , 2004, European Journal of Clinical Pharmacology.

[3]  P. Herrero,et al.  Myocardial Fatty Acid Metabolism: Independent Predictor of Left Ventricular Mass in Hypertensive Heart Disease , 2003, Hypertension.

[4]  A. Shillington,et al.  Survival in Primary Pulmonary Hypertension: The Impact of Epoprostenol Therapy , 2002, Circulation.

[5]  Gilles Garcia,et al.  Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival. , 2002, Journal of the American College of Cardiology.

[6]  J. Sandoval,et al.  Right ventricular ischemia in patients with primary pulmonary hypertension. , 2001, Journal of the American College of Cardiology.

[7]  T. Nakata,et al.  Two- and three-dimensional assessments of myocardial perfusion and function by using technetium-99m sestamibi gated SPECT with a combination of count- and image-based techniques , 2000, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[8]  Y. Kagaya,et al.  Long-term right ventricular volume overload increases myocardial fluorodeoxyglucose uptake in the interventricular septum in patients with atrial septal defect. , 2000, Circulation.

[9]  Inda,et al.  A COMPARISON OF CONTINUOUS INTRAVENOUS EPOPROSTENOL ( PROSTACYCLIN ) WITH CONVENTIONAL THERAPY FOR PRIMARY PULMONARY HYPERTENSION , 2000 .

[10]  V L Morgan,et al.  Normal human right and left ventricular mass, systolic function, and gender differences by cine magnetic resonance imaging. , 1999, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[11]  Y. Kagaya,et al.  Stimulated glucose uptake in the ischemic border zone: its dependence on glucose uptake in the normally perfused area. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[12]  G. Koch,et al.  Effects of Long-term Infusion of Prostacyclin (Epoprostenol) on Echocardiographic Measures of Right Ventricular Structure and Function in Primary Pulmonary Hypertension , 1997 .

[13]  B. Groves,et al.  Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension. Primary Pulmonary Hypertension Study Group. , 1997, Circulation.

[14]  B. Groves,et al.  A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. , 1996, The New England journal of medicine.

[15]  Y. Kagaya,et al.  Effects of chronic right ventricular pressure overload on myocardial glucose and free fatty acid metabolism in the conscious rat. , 1995, Cardiovascular research.

[16]  M. Weiner,et al.  Myocardial high-energy phosphate and substrate metabolism in swine with moderate left ventricular hypertrophy. , 1995, Circulation.

[17]  S. Vatner,et al.  Coronary vascular mechanisms involved in decompensation from hypertrophy to heart failure. , 1993, Journal of the American College of Cardiology.

[18]  Y. Kanno,et al.  Effects of long-term pressure overload on regional myocardial glucose and free fatty acid uptake in rats. A quantitative autoradiographic study. , 1990, Circulation.

[19]  M. Walsh,et al.  Assessment of myocardial oxidative metabolic reserve with positron emission tomography and carbon-11 acetate. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[20]  G. Buzzigoli,et al.  Coronary hemodynamics and myocardial metabolism during and after pacing stress in normal humans. , 1989, The American journal of physiology.

[21]  S. Rich.  Primary pulmonary hypertension , 1988 .

[22]  J. Wisneski,et al.  Myocardial substrate utilization during exercise in humans. Dual carbon-labeled carbohydrate isotope experiments. , 1988, The Journal of clinical investigation.

[23]  H. Taegtmeyer,et al.  Effects of moderate hypertension on cardiac function and metabolism in the rabbit. , 1988, Hypertension.

[24]  E H Bergofsky,et al.  Primary pulmonary hypertension. A national prospective study. , 1987, Annals of internal medicine.

[25]  Y. Yonekura,et al.  Regional myocardial substrate uptake in hypertensive rats: a quantitative autoradiographic measurement. , 1985, Science.

[26]  E. Braunwald.  Heart Disease: A Textbook of Cardiovascular Medicine , 1992, Annals of Internal Medicine.

[27]  D. Jewitt,et al.  Manual of Otolaryngology , 1969 .